Kyle Holen
Seminars
Thursday 2nd January 2025
Unveiling Moderna’s Latest Efforts to Target Rare Diseases with Protein Replacement Using mRNA Therapeutics
11:15 am
- Introducing Moderna’s latest expansions into rare diseases with mRNA protein therapy
- Revealing proof of concept from early stage trials against propionic and methylmalonic acidemia, and type 1 glycogen storage disease
- Discussing safety data from prolonged exposure to mRNA therapeutics targeted at the above indications
